QNRX

QUOIN PHARMACEUTICALS LTD

QNRX·74907L409·US·ADR·Healthcare - Biotechnology-13D/G

QNRX (QUOIN PHARMACEUTICALS LTD) is held by 8 institutional investors as of Q2 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($543,643), Woodline Partners LP ($369,999), Aberdeen Group plc ($363,000). Net institutional sentiment: Mixed.

8
Holders
$1.5M
Total Value
60% (10)
Consensus
6 buying - 4 selling
13F: Insider & Congress: Updated regularly
QNRX

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Oct 9, 2026 · Insiders Sep 1, 2026 · Activists Oct 7, 2026 · Congress none

ActivistIKIkarian Capital, LLC4.4%Oct 7, 2026
InsiderCPCarter Denise P.Buy $100KAug 31, 2026
InsiderLBLawlor Sally BridgetBuy $50KAug 31, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
112,323(+47.3%)$543,6430.0%-65.86%
33
Decreased
76,446(-3.9%)$369,9990.0%-66.30%
0
Unchanged
75,000$363,0000.0%-66.30%
0
Increased
21,469(+1551.5%)$103,9100.0%-5.21%
24
New
15,006$72,6290.0%-5.99%
29
Increased
8,000(+100.0%)$38,7200.0%-52.75%
22
Increased
6,772(+169.6%)$32,7770.0%-1.70%
22
Increased
2,332(+53.3%)$11,2800.0%-55.85%
17
Exited
0(-100.0%)$214,6250.0%-44.62%
0
Exited
0(-100.0%)$00.0%-44.62%
0
Exited
0(-100.0%)$396,0000.0%-50.08%
0
QNRXQNRXQUOIN PHARMACEUTICALS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used